As of 2025-06-25, the EV/EBITDA ratio of Taisho Pharmaceutical Holdings Co Ltd (4581.T) is
6.49.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4581.T's latest enterprise value
is 457,210.16 mil JPY. 4581.T's TTM EBITDA according to its financial statements is
70,404.00 mil JPY. Dividing these 2
quantities gives us the above 4581.T EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
4.5x - 5.9x |
5.2x |
| Forward P/E multiples |
5.3x - 7.9x |
6.7x |
| Fair Price |
5,954.26 - 8,069.72 |
7,072.79 |
| Upside |
-30.6% - -5.9% |
-17.6% |